Published in J Neurochem on August 01, 2005
Mutations in SYNGAP1 in autosomal nonsyndromic mental retardation. N Engl J Med (2009) 3.88
Topiramate and the vision: a systematic review. Clin Ophthalmol (2012) 1.48
Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence. Alcohol Clin Exp Res (2009) 1.07
Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med (2010) 1.05
Glutamatergic Synaptic Dysfunction and Obsessive-Compulsive Disorder. Curr Chem Genomics (2008) 0.95
Migraine prophylaxis, ischemic depolarizations, and stroke outcomes in mice. Stroke (2014) 0.95
Neuroprotective Strategies after Neonatal Hypoxic Ischemic Encephalopathy. Int J Mol Sci (2015) 0.84
Effects of food restriction and sucrose intake on synaptic delivery of AMPA receptors in nucleus accumbens. Synapse (2011) 0.84
Effect of repeated treatment with topiramate on voluntary alcohol intake and beta-endorphin plasma level in Warsaw alcohol high-preferring rats. Psychopharmacology (Berl) (2012) 0.82
The Impact of Anti-Epileptic Drugs on Growth and Bone Metabolism. Int J Mol Sci (2016) 0.81
Safety and efficacy of topiramate in neonates with hypoxic ischemic encephalopathy treated with hypothermia (NeoNATI). BMC Pediatr (2012) 0.81
Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0 T magnetic resonance spectroscopy study. Psychopharmacology (Berl) (2006) 0.80
Advances in Medications and Tailoring Treatment for Alcohol Use Disorder. Alcohol Res (2015) 0.78
Gabapentin activates ROMK1 channels by a protein kinase A (PKA)-dependent mechanism. Br J Pharmacol (2008) 0.77
Evaluation of Ocular Side Effects in the Patients on Topiramate Therapy for Control of Migrainous Headache. J Clin Diagn Res (2016) 0.75
Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date. CNS Drugs (2015) 0.75
Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 12.23
ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia (2006) 3.69
Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: a pooled analysis of three phase III studies. Epilepsia (2013) 1.89
Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation. Epilepsia (2007) 1.85
Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia (2013) 1.69
[Four years on a waiting lists for surgery--an expensive option. Millions in lost production while waiting for an orthopedic intervention]. Lakartidningen (2003) 1.66
Glial neuronal signaling in the central nervous system. FASEB J (2003) 1.51
Vigabatrin: 2008 update. Epilepsia (2009) 1.31
EP1-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality. Int J Cancer (2007) 1.19
Obstetric risks for women with epilepsy during pregnancy. Epilepsy Behav (2007) 1.10
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study. Epilepsy Res (2012) 1.03
Mental fatigue and impaired information processing after mild and moderate traumatic brain injury. Brain Inj (2009) 1.03
Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial. Epilepsy Res (2003) 1.01
Cognition-enhancing effect of vagus nerve stimulation in patients with Alzheimer's disease: a pilot study. J Clin Psychiatry (2002) 1.01
Lipopolysaccharide increases microglial GLT-1 expression and glutamate uptake capacity in vitro by a mechanism dependent on TNF-alpha. Glia (2005) 0.98
Efficacy and safety of eslicarbazepine acetate as add-on treatment in patients with focal-onset seizures: integrated analysis of pooled data from double-blind phase III clinical studies. Epilepsia (2012) 0.98
Utility of spine surgery: a comparison of common elective orthopaedic surgical procedures. Spine (Phila Pa 1976) (2008) 0.97
Issues related to development of new antiseizure treatments. Epilepsia (2013) 0.96
Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression. Acta Oncol (2007) 0.94
Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials. CNS Drugs (2010) 0.93
Novel mechanisms of action of three antiepileptic drugs, vigabatrin, tiagabine, and topiramate. Neurochem Res (2003) 0.93
Long-term safety of perampanel and seizure outcomes in refractory partial-onset seizures and secondarily generalized seizures: results from phase III extension study 307. Epilepsia (2014) 0.93
Levetiracetam reduces caffeine-induced Ca2+ transients and epileptiform potentials in hippocampal neurons. Neuroreport (2003) 0.92
Perampanel for adjunctive treatment of partial-onset seizures: a pooled dose-response analysis of phase III studies. Epilepsia (2014) 0.91
Effects of vagus nerve stimulation on rat hippocampal progenitor proliferation. Exp Neurol (2008) 0.90
The evolution of antiepileptic drug development and regulation. Epileptic Disord (2010) 0.90
A cost-effectiveness study of a patient-centred integrated care pathway. J Adv Nurs (2009) 0.89
Vagus nerve stimulation in patients with Alzheimer's disease: Additional follow-up results of a pilot study through 1 year. J Clin Psychiatry (2006) 0.88
Lactate induces tumour necrosis factor-alpha, interleukin-6 and interleukin-1beta release in microglial- and astroglial-enriched primary cultures. J Neurochem (2005) 0.88
Topiramate modulation of kainate-induced calcium currents is inversely related to channel phosphorylation level. J Neurochem (2004) 0.87
Naloxone and ouabain in ultralow concentrations restore Na+/K+-ATPase and cytoskeleton in lipopolysaccharide-treated astrocytes. J Biol Chem (2011) 0.86
Predicting a life-threatening disease and death among ambulance-transported patients with chest pain or other symptoms raising suspicion of an acute coronary syndrome. Am J Emerg Med (2002) 0.86
Implications for glycine receptors and astrocytes in ethanol-induced elevation of dopamine levels in the nucleus accumbens. Addict Biol (2011) 0.85
Sulfatide with short fatty acid dominates in astrocytes and neurons. FEBS J (2006) 0.84
A self-assessment questionnaire for mental fatigue and related symptoms after neurological disorders and injuries. Brain Inj (2010) 0.84
Microglial self-defence mediated through GLT-1 and glutathione. Amino Acids (2011) 0.84
A randomized, double-blind, placebo-controlled study of the efficacy, safety, and tolerability of adjunctive carisbamate treatment in patients with partial-onset seizures. Epilepsia (2011) 0.84
Glial cell line-derived neurotrophic factor is increased in cerebrospinal fluid but decreased in blood during long-term pain. J Neuroimmunol (2010) 0.83
Topiramate monotherapy in epilepsy and migraine prevention. Clin Ther (2005) 0.83
On the potential role of glutamate transport in mental fatigue. J Neuroinflammation (2004) 0.83
Radiation of the rat brain suppresses seizure-induced neurogenesis and transiently enhances excitability during kindling acquisition. Epilepsia (2007) 0.82
Insulin-like growth factor-I increases astrocyte intercellular gap junctional communication and connexin43 expression in vitro. J Neurosci Res (2003) 0.82
Expression of the myelin and oligodendrocyte progenitor marker sulfatide in neurons and astrocytes of adult rat brain. J Neurosci Res (2002) 0.82
Ifenprodil restores GDNF-evoked Ca(2+) signalling and Na(+)/K(+) -ATPase expression in inflammation-pretreated astrocytes. J Neurochem (2011) 0.82
Tumor genome wide DNA alterations assessed by array CGH in patients with poor and excellent survival following operation for colorectal cancer. Cancer Inform (2007) 0.81
The complement-derived anaphylatoxin C5a increases microglial GLT-1 expression and glutamate uptake in a TNF-alpha-independent manner. Eur J Neurosci (2009) 0.80
Topiramate protects against glutamate- and kainate-induced neurotoxicity in primary neuronal-astroglial cultures. Epilepsy Res (2003) 0.80
Exposure of cultured astroglial and microglial brain cells to 900 MHz microwave radiation. Radiat Res (2006) 0.80
Altered neuronal-glial signaling in glutamatergic transmission as a unifying mechanism in chronic pain and mental fatigue. Neurochem Res (2004) 0.80
Retigabine: has the orphan found a home? Epilepsy Curr (2007) 0.80
Proposal for a "phase II" multicenter trial model for preclinical new antiepilepsy therapy development. Epilepsia (2013) 0.80
Genes with relevance for early to late progression of colon carcinoma based on combined genomic and transcriptomic information from the same patients. Cancer Inform (2010) 0.80
Neurostimulation for epilepsy. Handb Clin Neurol (2012) 0.79
Lactate contributes to ammonia-mediated astroglial dysfunction during hyperammonemia. Neurochem Res (2008) 0.79
Inflammatory activation enhances NMDA-triggered Ca2+ signalling and IL-1β secretion in primary cultures of rat astrocytes. Brain Res (2012) 0.79
Anti-inflammatory substances can influence some glial cell types but not others. Brain Res (2013) 0.79
Primary cultures from cerebral cortex and hippocampus enriched in glutamatergic and GABAergic neurons. Neurochem Res (2010) 0.79
Person-centred care compared with standardized care for patients undergoing total hip arthroplasty--a quasi-experimental study. J Orthop Surg Res (2014) 0.79
Eslicarbazepine acetate: a well-kept secret? Epilepsy Curr (2010) 0.79
Ethanol acutely decreases astroglial gap junction permeability in primary cultures from defined brain regions. Neurochem Int (2004) 0.79
Microglial glutamate uptake is coupled to glutathione synthesis and glutamate release. Eur J Neurosci (2006) 0.79
Ultralow concentrations of bupivacaine exert anti-inflammatory effects on inflammation-reactive astrocytes. Eur J Neurosci (2013) 0.78
PACAP attenuates 5-HT, histamine, and ATP-evoked Ca2+ transients in astrocytes. Neuroreport (2009) 0.78
Long-term nicotine treatment suppresses IL-1β release and attenuates substance P- and 5-HT-evoked Ca²⁺ responses in astrocytes. Neurosci Lett (2013) 0.78
Early identification of patients with an acute coronary syndrome as assessed by dispatchers and the ambulance crew. Am J Emerg Med (2002) 0.78
Overcoming barriers to successful epilepsy management. Epilepsy Curr (2012) 0.78
Management of focal-onset seizures: an update on drug treatment. Drugs (2006) 0.77
Infantile spasms and epilepsy currents. Epilepsy Curr (2005) 0.77
Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures. Epilepsia (2009) 0.77
Novel computer tests for identification of mental fatigue after traumatic brain injury. NeuroRehabilitation (2015) 0.77
Mental fatigue and cognitive impairment after an almost neurological recovered stroke. ISRN Psychiatry (2012) 0.76
Is prolactin a clinically useful measure of epilepsy? Epilepsy Curr (2006) 0.76
Microglial GLT-1 is upregulated in response to herpes simplex virus infection to provide an antiviral defence via glutathione. Glia (2007) 0.76
Expression of delta opioid receptor mRNA and protein in the rat cerebral cortex and cerebellum is decreased by growth hormone. J Neurosci Res (2003) 0.76
Glial-neuronal signaling and astroglial swelling in physiology and pathology. Adv Exp Med Biol (2004) 0.76
Is topiramate tops? Epilepsy Curr (2008) 0.76
Comparison of prosthetic costs and service between osseointegrated and conventional suspended transfemoral prostheses. Prosthet Orthot Int (2012) 0.76
Some long awaited answers regarding seizures during pregnancy. Epilepsy Curr (2009) 0.75
Vigabatrin's complicated journey--to be or not to be? Epilepsy Curr (2009) 0.75
Seizure aggravation-evidence that oxcarbazepine requires monitoring. Epilepsy Curr (2008) 0.75
Vaccination and the onset of dravet syndrome. Epilepsy Curr (2011) 0.75
Commentary: ILAE definition of Epilepsy. Epilepsia (2014) 0.75